Differential expression of interleukin-8 and its receptors in the neuroendocrine and non-neuroendocrine compartments of prostate cancer

Jiaoti Huang, Jorge L. Yao, Li Zhang, Patricia A. Bourne, Andrew M. Quinn, P. Anthony Di Sant'Agnese, Jay E. Reeder

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

Hormonal therapy (androgen ablation and/or inhibition of androgen action) is the treatment of choice for advanced prostate cancer. After an initial response in most patients, tumors invariably progress to an androgen-independent state. It is unclear how prostate cancer cells proliferate without androgen. Recent studies suggest that interleukin-8 may promote androgen-independent proliferation, but the source of interleukin-8 in the prostate is unknown. Using immunohistochemistry, we show that interleukin-8 was expressed by the neuroendocrine tumor cells in human prostate cancer tissue. Expression of the interleukin-8 receptor CXCR1 was negative or low in benign prostatic tissue and was frequently increased in malignant cells of high-grade prostatic intraepithelial neoplasia and prostate cancer; however, CXCR1 was not detected in the neuroendocrine tumor cells, suggesting a paracrine mechanism by which interleukin-8 produced by neuroendocrine tumor cells stimulates androgen-independent proliferation of prostate cancer. Neuroendocrine tumor cells expressed another type of interleukin-8 receptor, CXCR2, suggesting an autocrine mechanism by which interleukin-8 regulates the differentiation or function of the neuroendocrine cells. These results, combined with previous reports that neuroendocrine differentiation is induced by hormonal therapy, suggest that neuroendocrine cells play an important role in promoting androgen-independent growth of prostate cancer through interleukin-8 signaling.

Original languageEnglish (US)
Pages (from-to)1807-1815
Number of pages9
JournalAmerican Journal of Pathology
Volume166
Issue number6
DOIs
StatePublished - Jan 1 2005

Fingerprint

Interleukin-8 Receptors
Neuroendocrine Cells
Androgens
Interleukin-8
Prostatic Neoplasms
Neuroendocrine Tumors
Prostatic Intraepithelial Neoplasia
Prostate
Therapeutics
Immunohistochemistry

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Differential expression of interleukin-8 and its receptors in the neuroendocrine and non-neuroendocrine compartments of prostate cancer. / Huang, Jiaoti; Yao, Jorge L.; Zhang, Li; Bourne, Patricia A.; Quinn, Andrew M.; Di Sant'Agnese, P. Anthony; Reeder, Jay E.

In: American Journal of Pathology, Vol. 166, No. 6, 01.01.2005, p. 1807-1815.

Research output: Contribution to journalArticle

Huang, Jiaoti ; Yao, Jorge L. ; Zhang, Li ; Bourne, Patricia A. ; Quinn, Andrew M. ; Di Sant'Agnese, P. Anthony ; Reeder, Jay E. / Differential expression of interleukin-8 and its receptors in the neuroendocrine and non-neuroendocrine compartments of prostate cancer. In: American Journal of Pathology. 2005 ; Vol. 166, No. 6. pp. 1807-1815.
@article{12e22c829c514f5499c9102fc352852f,
title = "Differential expression of interleukin-8 and its receptors in the neuroendocrine and non-neuroendocrine compartments of prostate cancer",
abstract = "Hormonal therapy (androgen ablation and/or inhibition of androgen action) is the treatment of choice for advanced prostate cancer. After an initial response in most patients, tumors invariably progress to an androgen-independent state. It is unclear how prostate cancer cells proliferate without androgen. Recent studies suggest that interleukin-8 may promote androgen-independent proliferation, but the source of interleukin-8 in the prostate is unknown. Using immunohistochemistry, we show that interleukin-8 was expressed by the neuroendocrine tumor cells in human prostate cancer tissue. Expression of the interleukin-8 receptor CXCR1 was negative or low in benign prostatic tissue and was frequently increased in malignant cells of high-grade prostatic intraepithelial neoplasia and prostate cancer; however, CXCR1 was not detected in the neuroendocrine tumor cells, suggesting a paracrine mechanism by which interleukin-8 produced by neuroendocrine tumor cells stimulates androgen-independent proliferation of prostate cancer. Neuroendocrine tumor cells expressed another type of interleukin-8 receptor, CXCR2, suggesting an autocrine mechanism by which interleukin-8 regulates the differentiation or function of the neuroendocrine cells. These results, combined with previous reports that neuroendocrine differentiation is induced by hormonal therapy, suggest that neuroendocrine cells play an important role in promoting androgen-independent growth of prostate cancer through interleukin-8 signaling.",
author = "Jiaoti Huang and Yao, {Jorge L.} and Li Zhang and Bourne, {Patricia A.} and Quinn, {Andrew M.} and {Di Sant'Agnese}, {P. Anthony} and Reeder, {Jay E.}",
year = "2005",
month = "1",
day = "1",
doi = "10.1016/S0002-9440(10)62490-X",
language = "English (US)",
volume = "166",
pages = "1807--1815",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Differential expression of interleukin-8 and its receptors in the neuroendocrine and non-neuroendocrine compartments of prostate cancer

AU - Huang, Jiaoti

AU - Yao, Jorge L.

AU - Zhang, Li

AU - Bourne, Patricia A.

AU - Quinn, Andrew M.

AU - Di Sant'Agnese, P. Anthony

AU - Reeder, Jay E.

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Hormonal therapy (androgen ablation and/or inhibition of androgen action) is the treatment of choice for advanced prostate cancer. After an initial response in most patients, tumors invariably progress to an androgen-independent state. It is unclear how prostate cancer cells proliferate without androgen. Recent studies suggest that interleukin-8 may promote androgen-independent proliferation, but the source of interleukin-8 in the prostate is unknown. Using immunohistochemistry, we show that interleukin-8 was expressed by the neuroendocrine tumor cells in human prostate cancer tissue. Expression of the interleukin-8 receptor CXCR1 was negative or low in benign prostatic tissue and was frequently increased in malignant cells of high-grade prostatic intraepithelial neoplasia and prostate cancer; however, CXCR1 was not detected in the neuroendocrine tumor cells, suggesting a paracrine mechanism by which interleukin-8 produced by neuroendocrine tumor cells stimulates androgen-independent proliferation of prostate cancer. Neuroendocrine tumor cells expressed another type of interleukin-8 receptor, CXCR2, suggesting an autocrine mechanism by which interleukin-8 regulates the differentiation or function of the neuroendocrine cells. These results, combined with previous reports that neuroendocrine differentiation is induced by hormonal therapy, suggest that neuroendocrine cells play an important role in promoting androgen-independent growth of prostate cancer through interleukin-8 signaling.

AB - Hormonal therapy (androgen ablation and/or inhibition of androgen action) is the treatment of choice for advanced prostate cancer. After an initial response in most patients, tumors invariably progress to an androgen-independent state. It is unclear how prostate cancer cells proliferate without androgen. Recent studies suggest that interleukin-8 may promote androgen-independent proliferation, but the source of interleukin-8 in the prostate is unknown. Using immunohistochemistry, we show that interleukin-8 was expressed by the neuroendocrine tumor cells in human prostate cancer tissue. Expression of the interleukin-8 receptor CXCR1 was negative or low in benign prostatic tissue and was frequently increased in malignant cells of high-grade prostatic intraepithelial neoplasia and prostate cancer; however, CXCR1 was not detected in the neuroendocrine tumor cells, suggesting a paracrine mechanism by which interleukin-8 produced by neuroendocrine tumor cells stimulates androgen-independent proliferation of prostate cancer. Neuroendocrine tumor cells expressed another type of interleukin-8 receptor, CXCR2, suggesting an autocrine mechanism by which interleukin-8 regulates the differentiation or function of the neuroendocrine cells. These results, combined with previous reports that neuroendocrine differentiation is induced by hormonal therapy, suggest that neuroendocrine cells play an important role in promoting androgen-independent growth of prostate cancer through interleukin-8 signaling.

UR - http://www.scopus.com/inward/record.url?scp=19544377849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19544377849&partnerID=8YFLogxK

U2 - 10.1016/S0002-9440(10)62490-X

DO - 10.1016/S0002-9440(10)62490-X

M3 - Article

C2 - 15920165

AN - SCOPUS:19544377849

VL - 166

SP - 1807

EP - 1815

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 6

ER -